These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 9088884

  • 1. Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment.
    Cavedini P, Erzegovesi S, Ronchi P, Bellodi L.
    Eur Neuropsychopharmacol; 1997 Feb; 7(1):45-9. PubMed ID: 9088884
    [Abstract] [Full Text] [Related]

  • 2. A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
    Milanfranchi A, Ravagli S, Lensi P, Marazziti D, Cassano GB.
    Int Clin Psychopharmacol; 1997 May; 12(3):131-6. PubMed ID: 9248868
    [Abstract] [Full Text] [Related]

  • 3. What is the optimal approach to the pharmacological management of obsessive-compulsive disorder?
    Ravindran AV.
    J Psychiatry Neurosci; 1998 Mar; 23(2):136. PubMed ID: 9549253
    [No Abstract] [Full Text] [Related]

  • 4. When fluvoxamine treats only depression and clomipramine treats only obsessive-compulsive disorder--combine them?
    Schaller JL, Behar D, Chamberlain T.
    J Neuropsychiatry Clin Neurosci; 1998 Mar; 10(1):111-3. PubMed ID: 9547477
    [No Abstract] [Full Text] [Related]

  • 5. [Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
    Kordon A, Broocks A, Hohagen F.
    MMW Fortschr Med; 2003 May 26; 145 Suppl 2():4-7. PubMed ID: 14579475
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M, Pini S, Bellantuono C, Wilkinson G.
    Br J Psychiatry; 1995 Apr 26; 166(4):424-43. PubMed ID: 7795913
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study.
    Mundo E, Bianchi L, Bellodi L.
    J Clin Psychopharmacol; 1997 Aug 26; 17(4):267-71. PubMed ID: 9241005
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder.
    Diniz JB, Costa DL, Cassab RC, Pereira CA, Miguel EC, Shavitt RG.
    J Psychopharmacol; 2014 Jun 26; 28(6):603-11. PubMed ID: 24288238
    [Abstract] [Full Text] [Related]

  • 10. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP, Trimble MR, Deakin JF, Stokes TM, Ashford JJ.
    J Clin Psychiatry; 1994 Jul 26; 55(7):301-5. PubMed ID: 8071291
    [Abstract] [Full Text] [Related]

  • 11. Long-term follow-up study of patients with refractory obsessive-compulsive disorder.
    Ross S, Fallon BA, Petkova E, Feinstein S, Liebowitz MR.
    J Neuropsychiatry Clin Neurosci; 2008 Jul 26; 20(4):450-7. PubMed ID: 19196930
    [Abstract] [Full Text] [Related]

  • 12. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
    Flament MF, Rapoport JL, Berg CJ, Sceery W, Kilts C, Mellström B, Linnoila M.
    Arch Gen Psychiatry; 1985 Oct 26; 42(10):977-83. PubMed ID: 3899048
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of axis II diagnoses on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder.
    Baer L, Jenike MA, Black DW, Treece C, Rosenfeld R, Greist J.
    Arch Gen Psychiatry; 1992 Nov 26; 49(11):862-6. PubMed ID: 1444723
    [Abstract] [Full Text] [Related]

  • 17. Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial.
    Bogetto F, Bellino S, Vaschetto P, Ziero S.
    Psychiatry Res; 2000 Oct 30; 96(2):91-8. PubMed ID: 11063782
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.